Clindamycin oral solution is a prescription liquid made from clindamycin palmitate hydrochloride granules. U.S. labeling describes a prepared concentration equivalent to 75 mg of clindamycin in 5 mL. The numbers describe concentration, not a universal patient dose, and must not be confused with the 75 mg capsule product.
Liquid administration may be considered when a prescriber has selected oral antibiotic therapy and a liquid form is appropriate. A pharmacy typically supplies a reconstituted preparation using the manufacturer’s directions. The amount a patient takes, the measuring device and storage instructions are specific to the dispensed product and prescription.
This page focuses on product identity, preparation and practical handoff questions. It is not a pediatric dose calculator. Caregivers can use the pediatric clindamycin guide for care and communication issues, while the oral-route hub covers capsules and systemic antibiotic risks.
A label reading 75 mg/5 mL expresses how much clindamycin equivalent is present in a measured volume after reconstitution. It differs fundamentally from “75 mg capsule,” where the number represents the amount in a single capsule. A caregiver should not infer a treatment dose from concentration alone.
The pharmacy label should state the prescribed amount using an appropriate unit, frequency and duration as directed by the clinician. If the printed directions, concentration or oral syringe markings are confusing, pause and ask the pharmacist to demonstrate the measurement before giving the medicine.
| Item on label | Meaning | Check before use |
|---|---|---|
| 75 mg/5 mL | Concentration of prepared oral liquid | Match the prescribed liquid formulation |
| Powder for solution | Pharmacy preparation is required | Confirm it has been reconstituted correctly |
| Dispensing directions | Patient-specific prescribed volume and schedule | Ask for demonstration if unclear |
| Oral syringe | Device for measuring liquid volume | Use pharmacy-provided equipment |
The palmitate hydrochloride product is formulated as granules for an oral solution; oral capsules contain clindamycin hydrochloride. Their labels and dosage forms should not be exchanged on the assumption that both contain “clindamycin.” Review the capsule product comparison if the written prescription names solid units.
A prescriber may choose a formulation based on clinical and administration considerations. The pharmacist must verify the actual product prescribed, prepared concentration and instructions rather than asking a caregiver to recalculate equivalents.
U.S. labeling for clindamycin palmitate granules describes a powder that must be reconstituted to yield clindamycin equivalent to 75 mg per 5 mL. Ask whether the pharmacy has prepared the bottle, confirmed the final concentration and recorded a preparation date. The stated final bottle volume is not a prescribed dose, and preparation instructions printed for pharmacy personnel must not be improvised by a caregiver.
At pickup, have the pharmacist identify the manufacturer and the mixed liquid on the dispensing record. Request a calibrated oral syringe, verify that the pharmacy label states the patient-specific volume in milliliters and ask what to do if powder is visible or the bottle looks improperly prepared. The separate Cleocin Pediatric brand guide identifies the branded label rather than providing a home mixing procedure.
Current Cleocin Pediatric labeling says to store the prepared solution at controlled room temperature, 20–25°C (68–77°F), and explicitly says not to refrigerate it. Chilling can make the liquid thicken and difficult to pour. The same branded label describes the reconstituted solution as stable for two weeks at room temperature; this is a shelf-life statement, not a reason to extend the prescribed antibiotic course.
Check the exact manufacturer and pharmacy-assigned discard date on the bottle because another product may have different instructions. Ask before using liquid past the stated discard date, after accidental freezing or when its appearance has changed. Do not use a refrigerator rule borrowed from amoxicillin or another pediatric antibiotic without checking this clindamycin product.
For oral liquids, consistent measurement is an important part of safe administration. A calibrated oral syringe suitable for the prescribed amount is generally clearer than an unmarked household spoon. If the pharmacist supplies a cup or another device, request a demonstration using the exact prescribed markings.
Never estimate volumes from a concentration printed on a carton. If a device is lost or the markings wear off, ask for a replacement and confirmation of the correct measurement before giving another dose.
Confirm the patient name, oral route, prepared concentration, written directions, total bottle volume and measuring device. Make sure the child or adult can take the preparation as directed and that the pharmacy explains what to do if some liquid is spilled or a dose is uncertain.
The prescription requirements guide describes how clinicians and pharmacies handle missing details. For stock questions, availability verification focuses on the correct formulation rather than a presumed supply of liquid products.
Liquid form does not eliminate the systemic risks of oral clindamycin. Serious antibiotic-associated diarrhea, including C. difficile colitis, may occur, and hypersensitivity reactions require attention. Promptly contact a clinician for concerning diarrhea, significant rash or other severe symptoms.
A liquid may make administration feasible, but it does not mean the medicine is automatically gentler or safer. The side-effects overview provides broader warning context; a child-specific clinical decision belongs with the treating clinician.
A pharmacy processing a clindamycin palmitate oral-liquid prescription should verify the active drug, 75 mg/5 mL concentration after mixing, required final quantity and appropriate dispensing directions. A catalog listing for unprepared granules does not tell the patient whether the bottle will arrive ready to measure. For shipped orders, ask which licensed pharmacy completes the reconstitution and how its stability window is communicated.
Verify state pharmacy licensing and access to a pharmacist as described in the online seller checklist. Product preparation and pharmacy authorization are separate: a legitimate pharmacy can still need to clarify a prescription before it can prepare the exact bottle.
A liquid quote must specify clindamycin palmitate for oral solution, the prepared 75 mg/5 mL concentration, final volume, brand or generic product and number of bottles. A capsule quote is not comparable because its pharmacy unit is a capsule rather than milliliters of prepared liquid. Ask whether the quote reflects the patient-ready product and the actual prescription quantity.
Insurance can apply different formulary rules to the prepared liquid and to capsule products. If cost is a barrier, ask the pharmacy about authorized substitutions or the prescriber about appropriate choices rather than reducing a prescribed volume. The cross-form cost guide covers general payment factors; this page stays specific to the solution.
Clindamycin palmitate solution is systemic antibiotic treatment. Its liquid flavor and ease of measurement do not remove the serious C. difficile-associated diarrhea warning. A history of clindamycin or lincomycin hypersensitivity, previous severe antibiotic-associated diarrhea, relevant medical conditions and recent antibiotics should be shared before treatment.
Contact the care team promptly about significant or persistent diarrhea, blood in stool, severe abdominal pain or suspected allergic symptoms during or after treatment. The adverse-effects reference explains route differences, but the liquid should be assessed using the systemic clindamycin label and the patient’s actual circumstances.
For a stock check, give the pharmacist the full product description: clindamycin palmitate hydrochloride granules for oral solution, intended 75 mg per 5 mL after reconstitution, and the prescribed final volume. An online search for “clindamycin 75 mg” may instead display a 75 mg capsule. Ask explicitly whether the listed item is powder to be prepared or an already compounded/dispensed liquid.
If a particular bottle size is unavailable, the pharmacist must reconcile any alternative with the order. Ask when preparation will occur and whether enough usable time remains before the assigned discard date. Do not assume that a label record, wholesaler catalog or checkout button confirms immediate supply.
Ask why a liquid was selected, which symptoms require re-evaluation, what exact volume will be measured and what to do if some medicine is spit out, spilled or cannot be swallowed. Do not give an extra dose or estimate a replacement volume without professional advice. A pharmacist can demonstrate the actual oral syringe markings using the prescription.
For pediatric care, the caregiver guide discusses child-specific communication and follow-up. For this form-level page, the decisive checkpoints are reconstitution, concentration, stability and measurement—not a generalized antibiotic purchase sequence.
Before the first administration, compare the patient name, clindamycin palmitate oral route, 75 mg/5 mL prepared concentration, prescribed mL amount and directions on the pharmacy label. The oral syringe should be clearly marked in milliliters and should suit the instructed volume. Ask about shaking or measuring instructions for the actual dispensed preparation.
Review the preparation date and discard date, keep the solution according to its label, and check specifically whether refrigeration is inappropriate. If directions, product appearance or storage advice conflict, contact the dispensing pharmacist rather than using a different antibiotic’s instructions. Finish with a clear plan for whom to call about significant diarrhea or an allergic reaction.
It is a prescription oral liquid prepared from clindamycin palmitate hydrochloride powder.
That is a concentration after reconstitution, not a universal patient dose.
No. The liquid is measured by volume and the capsule is a solid dosage unit.
A pharmacist typically reconstitutes the powder according to its product labeling before dispensing.
Use the pharmacy-provided calibrated dosing device and request a demonstration if the markings are unclear.
Cleocin Pediatric labeling states not to refrigerate the reconstituted solution because it may thicken; it describes room-temperature storage and two-week stability. Follow the exact dispensed product and pharmacy discard date.
The Cleocin Pediatric label advises against refrigeration because the liquid may thicken. Ask the dispensing pharmacist to assess the actual bottle and storage history before using it; do not guess whether it remains suitable.
The liquid is frequently relevant to pediatric care, but prescribing and formulation choice are determined by the clinician.
Severe or persistent diarrhea, bloody stools, significant allergic symptoms or worsening illness require timely professional assessment.